Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Kenealy

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
International Journal of Integrated Care|October 4, 2017
How do Policy and Institutional Settings Shape Opportunities for Community-Based Primary Health Care? A Comparison of Ontario, Québec and New ZealandTim Tenbensel, Fiona Miller, Mylaine Breton, et al.
Annals of Family Medicine|January 10, 2018
A Longitudinal Study of Interactions Between Health Professionals and People With Newly Diagnosed DiabetesAnthony Dowell, Maria Stubbe, Lindsay Macdonald, et al.
The New Zealand Medical Journal|February 23, 2010
A complex intervention to support 'rest home' care: a pilot studyShankar Sankaran, Tim Kenealy, Allan Adair, et al.
The Australian Journal of Rural Health|September 30, 2025
Type 2 Diabetes Management in Aotearoa New Zealand: A Comparison of Urban and Rural Primary Care ClinicsSara Mustafa, Mark Rodrigues, Ross Lawrenson, et al.
Journal of Primary Health Care|September 5, 2012
New Zealand Diabetes Cohort Study cardiovascular risk score for people with Type 2 diabetes: validation in the PREDICT cohortTom Robinson, C Raina Elley, Sue Wells, et al.
BMC Health Services Research|March 27, 2025
Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New ZealandLynne Chepulis, Mark Rodrigues, Han Gan, et al.
European Journal of Preventive Cardiology|October 4, 2012
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16Suneela Mehta, Sue Wells, Corina Grey, et al.
Diabetologia|May 22, 2026
Correction: SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic populationLynne Chepulis, Han Gan, David Simmons, et al.
Diabetologia|April 26, 2026
SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic populationLynne Chepulis, Han Gan, David Simmons, et al.
International Journal of Epidemiology|December 22, 2015
Cohort Profile: The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care (PREDICT-CVD 19)Sue Wells, Tania Riddell, Andrew Kerr, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
International Journal of Integrated Care|October 4, 2017
How do Policy and Institutional Settings Shape Opportunities for Community-Based Primary Health Care? A Comparison of Ontario, Québec and New ZealandTim Tenbensel, Fiona Miller, Mylaine Breton, et al.
Annals of Family Medicine|January 10, 2018
A Longitudinal Study of Interactions Between Health Professionals and People With Newly Diagnosed DiabetesAnthony Dowell, Maria Stubbe, Lindsay Macdonald, et al.
The New Zealand Medical Journal|February 23, 2010
A complex intervention to support 'rest home' care: a pilot studyShankar Sankaran, Tim Kenealy, Allan Adair, et al.
The Australian Journal of Rural Health|September 30, 2025
Type 2 Diabetes Management in Aotearoa New Zealand: A Comparison of Urban and Rural Primary Care ClinicsSara Mustafa, Mark Rodrigues, Ross Lawrenson, et al.
Journal of Primary Health Care|September 5, 2012
New Zealand Diabetes Cohort Study cardiovascular risk score for people with Type 2 diabetes: validation in the PREDICT cohortTom Robinson, C Raina Elley, Sue Wells, et al.
BMC Health Services Research|March 27, 2025
Real world initiation of newly funded empagliflozin and dulaglutide under special authority for patients with type 2 diabetes in New ZealandLynne Chepulis, Mark Rodrigues, Han Gan, et al.
European Journal of Preventive Cardiology|October 4, 2012
Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16Suneela Mehta, Sue Wells, Corina Grey, et al.
Diabetologia|May 22, 2026
Correction: SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic populationLynne Chepulis, Han Gan, David Simmons, et al.
Diabetologia|April 26, 2026
SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic populationLynne Chepulis, Han Gan, David Simmons, et al.
International Journal of Epidemiology|December 22, 2015
Cohort Profile: The PREDICT Cardiovascular Disease Cohort in New Zealand Primary Care (PREDICT-CVD 19)Sue Wells, Tania Riddell, Andrew Kerr, et al.
Pageof 7